New questionnaire aims to measure life quality in pituitary tumor patients
NCT ID NCT04106531
First seen Jan 10, 2026 · Last updated May 14, 2026 · Updated 17 times
Summary
This study aimed to validate a new questionnaire called Prolac-10, designed to measure quality of life in people with prolactinoma (a type of pituitary tumor) who are starting medical therapy. Researchers planned to enroll adults diagnosed with prolactinoma to test how well the questionnaire captures changes in well-being. However, the study was terminated early and only included 8 participants, so its results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROLACTINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ohio State University
Columbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.